Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRDLTSE:HLSTSE:TGODCVE:VM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRDLCardiol Therapeutics$1.34+4.7%$1.20$0.77▼$2.63$105.79M1.03313,709 shs126,875 shsHLSHLS TherapeuticsC$4.94-1.0%C$4.68C$3.00▼C$5.23C$109.90M1.0713,368 shs3,802 shsTGODGreen Organic DutchmanC$0.00C$0.17▼C$0.65C$89.95MN/A2.66 million shs19.70 million shsVMVoyageur PharmaceuticalsC$0.24-4.0%C$0.18C$0.04▼C$0.25C$36.36M0.32190,030 shs321,434 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRDLCardiol Therapeutics+3.23%-10.49%+16.36%+20.75%-30.81%HLSHLS Therapeutics+0.60%0.00%+6.62%+15.78%+45.27%TGODGreen Organic Dutchman0.00%0.00%0.00%0.00%0.00%VMVoyageur Pharmaceuticals+4.17%+13.64%+47.06%+38.89%+194.12%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRDLCardiol Therapeutics2.4744 of 5 stars3.72.00.00.03.60.00.6HLSHLS Therapeutics0.7407 of 5 stars1.00.01.70.01.83.30.0TGODGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/AVMVoyageur PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRDLCardiol Therapeutics 3.40Buy$8.67546.77% UpsideHLSHLS Therapeutics 2.00HoldC$4.50-8.91% DownsideTGODGreen Organic Dutchman 0.00N/AN/AN/AVMVoyageur Pharmaceuticals 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VM, CRDL, HLS, and TGOD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$9.004/16/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.004/7/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.003/26/2025HLSHLS TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHoldC$3.50 ➝ C$4.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRDLCardiol TherapeuticsN/AN/AN/AN/A$0.22 per shareN/AHLSHLS TherapeuticsC$40.13M2.74C$0.32 per share15.22C$2.51 per share1.97TGODGreen Organic DutchmanC$31.37M0.00N/A10.63C$0.26 per share0.00VMVoyageur PharmaceuticalsN/AN/AC$0.01 per share35.00C$0.01 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRDLCardiol Therapeutics-$26.77M-$0.34N/AN/AN/AN/A-209.63%-141.09%7/14/2025 (Estimated)HLSHLS Therapeutics-C$15.53M-C$1.00N/A∞N/A-38.70%-25.27%-2.89%N/ATGODGreen Organic DutchmanN/A-C$0.26N/AN/AN/AN/AN/AN/AN/AVMVoyageur Pharmaceuticals-C$1.66M-C$0.01N/A∞N/AN/A-117.77%-30.77%N/ALatest VM, CRDL, HLS, and TGOD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/31/2025Q4 2024CRDLCardiol Therapeutics-$0.08-$0.07+$0.01-$0.07N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRDLCardiol TherapeuticsN/AN/AN/AN/AN/AHLSHLS TherapeuticsC$0.204.05%N/AN/A N/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/AVMVoyageur PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRDLCardiol Therapeutics0.013.263.26HLSHLS Therapeutics86.501.561.01TGODGreen Organic Dutchman16.771.280.50VMVoyageur Pharmaceuticals4.230.100.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRDLCardiol Therapeutics12.49%HLSHLS Therapeutics65.20%TGODGreen Organic DutchmanN/AVMVoyageur PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipCRDLCardiol Therapeutics5.25%HLSHLS Therapeutics0.37%TGODGreen Organic DutchmanN/AVMVoyageur Pharmaceuticals10.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRDLCardiol Therapeutics2082.65 million78.31 millionNot OptionableHLSHLS Therapeutics9122.25 millionN/ANot OptionableTGODGreen Organic Dutchman41529.14 millionN/ANot OptionableVMVoyageur PharmaceuticalsN/A151.52 millionN/ANot OptionableVM, CRDL, HLS, and TGOD HeadlinesRecent News About These CompaniesVoyageur Pharmaceuticals Launches First Commercial Sale of Barium Contrast AgentsJune 4, 2025 | msn.comVoyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study ResultsApril 24, 2025 | finance.yahoo.comVoyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market LaunchApril 1, 2025 | finance.yahoo.comVoyageur Pharmaceuticals Ltd.: Voyageur Clarifies Terms of Previously Announced AgreementMarch 3, 2025 | finanznachrichten.deVoyageur Advances MRI Drug Development Using Next Generation Endohedral FullerenesFebruary 18, 2025 | finance.yahoo.comVoyageur Pharmaceuticals With CEO, Brent Willis | February 6th, 2025February 6, 2025 | msn.comVoyageur Receives $600K Grant From Alberta Innovates for Product DevelopmentFebruary 6, 2025 | finance.yahoo.comVoyageur Secures $687k of Additional Capital From Warrant ExercisesJanuary 24, 2025 | finance.yahoo.comVoyageur Pharmaceuticals is going global: Why it's time to buy the stockJanuary 23, 2025 | msn.comCanadian Investment Regulatory Organization Trading Halt - VMDecember 22, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - VMDecember 22, 2024 | finance.yahoo.comOne of the best Venture pharma stocks has grown even strongerOctober 3, 2024 | msn.comVoyageur Pharmaceuticals Ltd (VM)August 10, 2024 | investing.comUpdate - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium ContrastMay 28, 2024 | finance.yahoo.comVoyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonMarch 13, 2024 | proactiveinvestors.comVoyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug DevelopmentMarch 13, 2024 | thenewswire.comVoyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug AdvancementMarch 4, 2024 | thenewswire.comVoyageur Pharmaceuticals Ltd. Announces Closing of Private PlacementMarch 1, 2024 | thenewswire.comVoyageur Pharmaceuticals Ltd. Announces Private PlacementJanuary 16, 2024 | thenewswire.comVoyageur Pharmaceuticals Ltd VMJanuary 3, 2024 | morningstar.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVM, CRDL, HLS, and TGOD Company DescriptionsCardiol Therapeutics NASDAQ:CRDL$1.34 +0.06 (+4.69%) Closing price 04:00 PM EasternExtended Trading$1.37 +0.03 (+2.24%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.HLS Therapeutics TSE:HLSC$4.94 -0.05 (-1.00%) As of 02:19 PM EasternHLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.Green Organic Dutchman TSE:TGODThe Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.Voyageur Pharmaceuticals CVE:VMC$0.24 -0.01 (-4.00%) As of 03:59 PM EasternVoyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
